Reported 0 shares, down 307,266 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 155000 |
| 2022-03-31 | 427000 |
| 2022-06-30 | 357000 |
| 2022-09-30 | 639000 |
| 2022-12-31 | 344000 |
| 2023-03-31 | 350283 |
| 2023-06-30 | 172099 |
| 2023-09-30 | 26609 |
| 2023-12-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2023 | Reduced | 0 | -307,266 (-100.0%) | 0 | $0 | 2024-02-13 | |
| Q3 2023 | Unchanged | 307,266 | 0 (0.0%) | < 0.01% | $26,609 | 2023-11-13 | |
| Q2 2023 | Unchanged | 307,266 | 0 (0.0%) | < 0.01% | $172,099 | 2023-08-11 | |
| Q1 2023 | Unchanged | 307,266 | 0 (0.0%) | < 0.01% | $350,283 | 2023-05-15 | |
| Q4 2022 | Added | 307,266 | +2,884 (0.9%) | < 0.01% | $344,000 | 2023-02-13 | |
| Q3 2022 | Added | 304,382 | +41,605 (15.8%) | < 0.01% | $639,000 | 2022-11-14 | |
| Q2 2022 | Added | 262,777 | +9,692 (3.8%) | < 0.01% | $357,000 | 2022-08-12 | |
| Q1 2022 | Added | 253,085 | +109,423 (76.2%) | < 0.01% | $427,000 | 2022-05-13 | |
| Q4 2021 | Reduced | 143,662 | -2,770 (-1.9%) | < 0.01% | $155,000 | 2022-02-11 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
36 managers reported RVL PHARMACEUTICALS PLC ORDINA for Q4 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| XTX Topco Ltd | New | 180,566 | +180,566 | < 0.01% | $542 | 1 qtr |
| RAYMOND JAMES & ASSOCIATES | New | 23,696 | +23,696 | < 0.01% | $71 | 1 qtr |
| BlackRock Inc | Reduced | 0 | -225,721 | 0 | $0 | 21 qtrs |
| FMR LLC | Reduced | 0 | -500 | 0 | $0 | 2 qtrs |
| JPMorgan Chase & Co | Reduced | 0 | -3 | 0 | $0 | 21 qtrs |
| Qube Research & Technologies Ltd | Reduced | 0 | -50 | 0 | $0 | 2 qtrs |
| ADVISOR GROUP HOLDINGS INC | Reduced | 0 | -1,187 | 0 | $0 | 14 qtrs |
| Williams Jones Wealth Management LLC | Reduced | 0 | -10,000 | 0 | $0 | 8 qtrs |
| THE BANK OF NEW YORK MELLON CORPORATION | Reduced | 0 | -12,078 | 0 | $0 | 20 qtrs |
| LPL Financial LLC | Reduced | 0 | -21,210 | 0 | $0 | 4 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2023
- Filed
- February 13, 2024
- Filing type
- 13F-HR
- Position type
- SHS
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.